Sgsm2 has great potential to act as a regulator of the epithelial–mesenchymal transition process in renal fibrosis by decreasing the expression of epithelial markers and increasing the expression of mesenchymal proteins. The gene discussed is SGSM2; the disease is renal fibrosis.